Demyelination and neurodegenerative changes in serum IgG antibodies to GM1, GD1a and GM3 gangliosides in a patient on dialysis
Neurological Disorders and Therapeutics · 2017
DOI: 10.15761/ndt.1000105 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurological Disorders and Therapeutics, 2017. Verfasst von Vera Kolyovska und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kolyovska, V., Pavlova, V., Iliev, I., & Ivanova, S. (2017). Demyelination and neurodegenerative changes in serum IgG antibodies to GM1, GD1a and GM3 gangliosides in a patient on dialysis. Neurological Disorders and Therapeutics. https://doi.org/10.15761/ndt.1000105
Vancouver
Kolyovska V, Pavlova V, Iliev I, Ivanova S. Demyelination and neurodegenerative changes in serum IgG antibodies to GM1, GD1a and GM3 gangliosides in a patient on dialysis. Neurological Disorders and Therapeutics. 2017. doi:10.15761/ndt.1000105
BibTeX
@article{Kolyovska2017,
author = {Kolyovska, Vera and Pavlova, Velichka and Iliev, Ivan and Ivanova, Sonya},
title = {Demyelination and neurodegenerative changes in serum IgG antibodies to GM1, GD1a and GM3 gangliosides in a patient on dialysis},
journal = {Neurological Disorders and Therapeutics},
year = {2017},
doi = {10.15761/ndt.1000105}
}
EUVIMED